EOS INC. - Quarter Report: 2023 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
x |
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE QUARTERLY PERIOD ENDED: June 30, 2023
¨ |
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT |
FOR THE TRANSITION PERIOD FROM __________ TO __________
Commission File Number: 000-55661
EOS Inc. |
(Exact name of registrant as specified in its charter) |
Nevada |
|
30-0873246 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
4F-1, No.5, Qingdao E. Rd
., Zhongzheng Dist.,Taipei City 100008 Taiwan (Republic of China)
(Address of principal executive offices, Zip Code)
+
886
2
-2586-8300(Registrant’s telephone number, including area code)
|
N/A |
|
|
(Former name or former address, if changed since last report) |
|
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common |
|
EOSS |
|
|
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was require
d t
o file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x
No
¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes
x
No
¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated f
iler
,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
¨ |
Accelerated filer |
¨ |
Non-accelerated filer |
x |
Smaller reporting company |
x |
|
Emerging growth company |
x |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
¨
No
x
A
s of August 1
4
2023, t
he number of shares of registrant’s common stock outstanding is 183,781,560.
EOS, Inc.
Table of Contents
2 |
The following unaudited interim condensed consolidated financial statements of EOS Inc. are included in this Quarterly Report on Form 10
-Q:
INDEX TO FINANCIAL STATEMENT
F-1 |
EOS, INC. AND SUBSIDIARIES
As of June 30, 2023 and December 31, 2022
Unaudited
June 30, | December 31, | |||||||
2023 | 2022 | |||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 26,600 | $ | 18,169 | ||||
Accounts receivable | 129,698 | 160,253 | ||||||
Inventory, net | 84,658 | 46,196 | ||||||
Advances to suppliers | 159,422 | 166,594 | ||||||
Security deposits | - | 6,608 | ||||||
Prepaid expenses and other current assets | 15,647 | 28,096 | ||||||
Total Current Assets | 416,025 | 425,916 | ||||||
Non-Current Assets | ||||||||
Property, plant and equipment, net | 5,283 | 4,692 | ||||||
Other non-current assets | 192 | - | ||||||
Operating lease right of use asset | 96,579 | 115,884 | ||||||
Loans receivable from related parties, net | - | - | ||||||
Total Non-Current Assets | 102,054 | 120,576 | ||||||
Total Assets | 518,079 | 546,492 | ||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current Liabilities | ||||||||
Other payable and accrued expenses | 51,125 | 73,352 | ||||||
Due to shareholders | 505,709 | 277,080 | ||||||
Income taxes payable | 47,764 | 49,074 | ||||||
Other current liabilities | 875,116 | 750,000 | ||||||
Operating lease liabilities - current | 35,138 | 48,231 | ||||||
Current portion of long-term loan payables | 58,941 | 68,497 | ||||||
Total Current Liabilities | 1,573,793 | 1,266,234 | ||||||
Non-Current Liabilities | ||||||||
Long-term loan payables | 86,644 | 116,012 | ||||||
Operating lease liabilities - non-current | 61,441 | 80,538 | ||||||
Total Non-Current Liabilities | 148,085 | 196,550 | ||||||
Total Liabilities | 1,721,878 | 1,462,784 | ||||||
Commitments and Contingencies | - | - | ||||||
Shareholders’ Equity | ||||||||
Preferred stock ($0.001 par value, 5,000,000 shares authorized, 1,500,000 sha res issued and outstanding as of June 30, 2023 and | 1,500 | 1,500 | ||||||
Common stock ($0.001 par value; 575,000,000 shares authorized, 183,781,560 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively) | 183,781 | 183,781 | ||||||
Additional paid in capital | 67,249 | 67,249 | ||||||
Deferred stock compensation | (40,674 | ) | (40,674 | ) | ||||
Retained earnings | (1,456,128 | ) | (1,165,665 | ) | ||||
Accumulated other comprehensive loss | 50,349 | 42,964 | ||||||
Total equity attributable to EOS, Inc. | (1,193,923 | ) | (910,845 | ) | ||||
Non-controlling interest | (9,876 | ) | (5,447 | ) | ||||
Total Equity | (1,203,799 | ) | (916,292 | ) | ||||
Total Liabilities and Shareholders’ Equity | $ | 518,079 | $ | 546,492 |
The accompanying notes are an integral part of these consolidated financial statements.
F-2 |
EOS, INC. AND SUBSIDIARIES
For the Three and Six Months Ended June 30, 2023 and 2022
Unaudited
|
|
Three Months Ended |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
Six Months Ended |
|
||||
|
|
June 30, |
|
|
June 30, |
|
|
June 30, |
|
|
June 30, |
|
||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
Net sales |
|
$ |
82,426 |
|
|
$ |
99,121 |
|
|
$ |
253,505 |
|
|
$ |
132,185 |
|
Cost of sales |
|
|
28,530 |
|
|
|
42,224 |
|
|
|
86,703 |
|
|
|
48,899 |
|
Gross profit |
|
|
53,896 |
|
|
|
56,897 |
|
|
|
166,802 |
|
|
|
83,286 |
|
Selling, general and administrative expenses |
|
|
218,537 |
|
|
|
210,571 |
|
|
|
460,863 |
|
|
|
440,654 |
|
Income (Loss) from operations |
|
|
(164,641 |
) |
|
|
(153,674 |
) |
|
|
(294,061 |
) |
|
|
(357,368 |
) |
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income (expense) |
|
|
(1,226 |
) |
|
|
(789 |
) |
|
|
(2,609 |
) |
|
|
(1,669 |
) |
Other income (expense) |
|
|
759 |
|
|
|
7,370 |
|
|
|
1,425 |
|
|
|
4,865 |
|
Total other income (expense) |
|
|
(467 |
) |
|
|
6,581 |
|
|
|
(1,184 |
) |
|
|
3,196 |
|
Loss before income tax provision |
|
|
(165,108 |
) |
|
|
(147,093 |
) |
|
|
(295,245 |
) |
|
|
(354,172 |
) |
Income tax expenses (benefits) |
|
|
- |
|
|
|
(10,475 |
) |
|
|
- |
|
|
|
(10,475 |
) |
Net Loss |
|
$ |
(165,108 |
) |
|
$ |
(136,618 |
) |
|
$ |
(295,245 |
) |
|
$ |
(343,697 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Comprehensive Income (Loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to non-controlling interests |
|
$ |
(2,882 |
) |
|
|
(2,071 |
) |
|
|
(4,782 |
) |
|
|
(6,162 |
) |
Net income (loss) attributable to EOS and subsidiaries |
|
|
(162,226 |
) |
|
|
(134,547 |
) |
|
|
(290,463 |
) |
|
|
(337,535 |
) |
Foreign currency translation adjustment, net of tax |
|
|
8,532 |
|
|
|
(41,696 |
) |
|
|
7,738 |
|
|
|
(86,619 |
) |
Comprehensive loss |
|
$ |
(156,576 |
) |
|
$ |
(178,314 |
) |
|
$ |
(287,507 |
) |
|
$ |
(430,316 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
(0.001 |
) |
|
$ |
(0.001 |
) |
|
$ |
(0.002 |
) |
|
$ |
(0.002 |
) |
Weighted average number of common shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
183,781,560 |
|
|
|
181,821,311 |
|
|
|
183,781,560 |
|
|
|
180,948,133 |
|
The accompanying notes are an integral part of these consolidated financial statements.
F-3 |
EOS, INC. AND SUBSIDIARIES
For the Six Months Ended June 30, 2023 and 2022
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
Equity |
|
|
|
|
|
||||
|
Common Stock |
Preferred Stock |
Deferred |
Additional |
|
|
other |
attributable |
Non- |
|||||||||||||||||||||||||
|
|
Number of |
|
|
|
Number of |
|
|
|
Stock |
|
Paid-in |
|
Retained |
|
Comprehensive |
|
to |
|
Controlling |
|
Total |
|
|||||||||||
|
Shares |
Amount |
Shares |
Amount |
Compensation |
Capital |
Earnings |
Income (Loss) |
EOS, Inc. |
interest |
Equity |
|
||||||||||||||||||||||
Balance at December 31, 2021 |
|
|
180,065,254 |
|
180,065 |
|
$ |
1,500,000 |
|
1,500 |
|
$ |
- |
|
$ |
29,060 |
|
$ |
722,925 |
|
$ |
133,056 |
|
$ |
1,066,606 |
|
$ |
19,562 |
|
$ |
1,086,168 |
|
||
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(44,080 |
) |
|
(44,080 |
) |
|
(843 |
) |
|
(44,923 |
) |
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(202,988 |
) |
|
- |
|
|
(202,988 |
) |
|
(4,091 |
) |
|
(207,079 |
) |
Balance at March 31, 2022 |
|
|
180,065,254 |
|
|
180,065 |
|
|
1,500,000 |
|
|
1,500 |
|
|
- |
|
|
29,060 |
|
|
519,937 |
|
|
88,976 |
|
|
819,538 |
|
|
14,628 |
|
|
834,166 |
|
Share issued for compensation |
|
|
115,000 |
|
|
115 |
|
|
- |
|
|
- |
|
|
- |
|
|
1,116 |
|
|
- |
|
|
- |
|
|
1,231 |
|
|
- |
|
|
1,231 |
|
Deferred compensation expense relating to issuance of restricted common stock |
|
|
3,601,306 |
|
|
3,601 |
|
|
- |
|
|
- |
|
|
(38,534 |
) |
|
34,933 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Deferred compensation expense relating to issuance of warrant |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(2,140 |
) |
|
2,140 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(40,980 |
) |
|
(40,980 |
) |
|
(714 |
) |
|
(41,694 |
) |
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(134,547 |
) |
|
- |
|
|
(134,547 |
) |
|
(2,071 |
) |
|
(136,618 |
) |
Balance at June 30, 2022 |
|
|
183,781,560 |
|
|
183,781 |
|
|
1,500,000 |
|
|
1,500 |
|
|
(40,674 |
) |
|
67,249 |
|
|
385,390 |
|
|
47,996 |
|
|
645,242 |
|
|
11,843 |
|
|
657,085 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2022 |
|
|
183,781,560 |
|
|
183,781 |
|
|
1,500,000 |
|
|
1,500 |
|
|
(40,674 |
) |
|
67,249 |
|
|
(1,165,665 |
) |
|
42,964 |
|
|
(910,845 |
) |
|
(5,447 |
) |
|
(916,292 |
) |
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(727 |
) |
|
(727 |
) |
|
(67 |
) |
|
(794 |
) |
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(128,237 |
) |
|
- |
|
|
(128,237 |
) |
|
(1,900 |
) |
|
(130,137 |
) |
Balance at March 31, 2023 |
|
|
183,781,560 |
|
$ |
183,781 |
|
$ |
1,500,000 |
|
$ |
1,500 |
|
$ |
(40,674 |
) |
$ |
67,249 |
|
$ |
(1,293,902 |
) |
$ |
42,237 |
|
$ |
(1,039,809 |
) |
$ |
(7,414 |
) |
$ |
(1,047,223 |
) |
Foreign currency translation adjustment |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
8,112 |
|
|
8,112 |
|
|
420 |
|
|
8,532 |
|
Net loss |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(162,226 |
) |
|
- |
|
|
(162,226 |
) |
|
(2,882 |
) |
|
(165,108 |
) |
Balance at June 30, 2023 |
|
|
183,781,560 |
|
$ |
183,781 |
|
$ |
1,500,000 |
|
$ |
1,500 |
|
$ |
(40,674 |
) |
$ |
67,249 |
|
$ |
(1,456,128 |
) |
$ |
50,349 |
|
$ |
(1,193,923 |
) |
$ |
(9,876 |
) |
$ |
(1,203,799 |
) |
The accompanying notes are an integral part of these consolidated financial statements.
F-4 |
EOS, INC. AND SUBSIDIARIES
For the Six Months Ended June 30, 2023 and 2022
Unaudited
|
|
Six Months Ended |
|
|
Six Months Ended |
|
||
|
|
June 30, |
|
|
June 30, |
|
||
|
|
2023 |
|
|
2022 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(295,245 |
) |
|
$ |
(343,697 |
) |
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
- |
|
|
|
- |
|
Bad debt recovery |
|
|
- |
|
|
|
(17,900 |
) |
Depreciation |
|
|
408 |
|
|
|
636 |
|
Amortization of right-of-use asset |
|
|
- |
|
|
|
18,138 |
|
Stock based compensation |
|
|
- |
|
|
|
1,231 |
|
Changes in assets and liabilities |
|
|
- |
|
|
|
- |
|
Decrease in accounts receivable |
|
|
28,424 |
|
|
|
235,129 |
|
I ncrease in inventory |
|
|
(40,022 |
) |
|
|
(117,044 |
) |
Decrease in advance to suppliers |
|
|
4,357 |
|
|
|
45,759 |
|
Decrease (increase) in security deposits and other assets |
|
|
18,649 |
|
|
|
(2,834 |
) |
Increase |
|
|
- |
|
|
|
52,706 |
|
Increase in accrued expenses |
|
|
103,771 |
|
|
|
90,258 |
|
Dec rease in advances from customers |
|
|
(12,925 |
) |
|
|
- |
|
Increase (decreas in income tax payablee) |
|
|
865 |
|
|
|
(7,911 |
) |
D ecrease in operating lease liabilities |
|
|
- |
|
|
|
(18,138 |
) |
Net cash |
|
|
(191,718 |
) |
|
|
(63,667 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchase of equipment |
|
|
(1,091 |
) |
|
|
(19,919 |
) |
Net cash used in investing activities |
|
|
(1,091 |
) |
|
|
(19,919 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Repayment to related party |
|
|
(51,831 |
) |
|
|
(114,378 |
) |
Proceeds from related party |
|
|
290,075 |
|
|
|
304,088 |
|
Repayment to borrowings |
|
|
(36,546 |
) |
|
|
(38,992 |
) |
Net cash provided by financing activities |
|
|
201,698 |
|
|
|
150,718 |
|
|
|
|
|
|
|
|
|
|
Effect of foreign currency translation on cash and cash equivalents |
|
|
(458 |
) |
|
|
(3,945 |
) |
Net increase of cash and cash equivalents |
|
|
8,431 |
|
|
|
63,187 |
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, and restricted cash |
|
|
|
|
|
|
|
|
Beginning |
|
|
18,169 |
|
|
|
24,141 |
|
Ending |
|
$ |
26,600 |
|
|
$ |
87,328 |
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosure of Cash Flows |
|
|
|
|
|
|
|
|
Cash paid during the periods for: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
2,666 |
|
|
$ |
1,682 |
|
Income taxes |
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
Non-cash financing and investing activities: |
|
|
|
|
|
|
|
|
Deferred compensation expense relating to issuance of restricted common stock |
|
$ |
- |
|
|
$ |
38,534 |
|
Deferred compensation expense relating to issuance of warrant |
|
$ |
- |
|
|
$ |
2,140 |
|
The accompanying notes are an integral part of these consolidated financial statements.
F-5 |
NOTES TO
CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Note 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial reporting and in accordance with instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end balance sheet data were derived from audited consolidated financial statements, but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year. These unaudited condensed consolidated financial statements, footnote disclosures, and other information should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
Organization
EOS Inc. was incorporated on April 3, 2015 in the State of Nevada. The Company’s business plan is to market and distribute skin care products, including masks and serums.
On November 18, 2016, the Company set up a wholly-owned subsidiary in Taiwan to assist the Company to promote the business in Taiwan.
Emperor Star International Trade Co., Ltd., (“Emperor Star”), was incorporated on November 16, 2015 under the laws of Taiwan. Emperor Star is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifiers.
On May 3, 2017, the Company entered into and closed a Share Purchase and Sale Agreement (the “Purchase Agreement”) with Emperor Star and the shareholder of Emperor Star to acquire all issued and outstanding shares of Emperor Star in consideration of $30,562 in cash. As a result of the Purchase Agreement, Emperor Star became the Company’s wholly owned subsidiary. Upon consummation of the transaction, the Company has assumed the business of Emperor Star and ceased to be a shell company.
On September 20, 2018, the Company set up another wholly-owned subsidiary, EOS International Inc. (“EOS(BVI)”), under the laws of British Virgin Islands. EOS(BVI) is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifiers.
On March 1, 2019, EOS(BVI) set up a wholly-owned subsidiary, Shanghai Maosong Co., Ltd (“Maosong”), under the laws of People’s Republic of China. Maosong is in the business of marketing and distribution of various products, including nutrition supplements, skin care products, and water purifiers in China. As of the date of this report, Maosong has a registered capital of USD $100,000, but no capital has actually been paid into Maosong.
On June 2, 2020, EOS(BVI) 83.33% owner, and Shanghai Qifan Qiye Management Co., Ltd. (“Qifan”) 16.67% owner of Maosong resolute to change the registered capital of Maosong to RMB 1,200,000,000 (1.2 billion) and that EOS to contribute certain Intellectual Property as registered capital of Shanghai Maosong. Intellectual Property owned by EOS International Inc was valued at RMB 1,000,000,000 (1 billion) and Intellectual Property owned by Qifan was valued at RMB 200,000,000 (200 million).
On July 13, 2021, EOS(BVI), MaoSong, and Qifan entered into a Shareholder Agreement where Qifan (i) delegate its 16.67% equity voting rights, powers, or benefits in Maosong to EOS(BVI); (ii) grant EOS(BVI) an irrevocable, unconditional, exclusive option to purchase Maosong’s equity interest; (iii) the right to receive any proceeds from the Maosong’s Equity Interest; (iv) pledge its existing or any prospective Maosong equity interest to EOS Int’l; as a result EOS(BVI) retains 100% control of MaoSong and the 16.67% noncontrolling interest are consolidated.
F-6 |
Principles of Consolidation
The accompanying
condensed
consolidated financial statements, including the accounts of EOS Inc. and its wholly owned subsidiaries in Taiwan, British Virgin Islands, and People’s Republic of China, have been prepared in conformity with accounting principles generally accepted in the United States of America. Since the Company and Emperor Star are entities under common control prior to the acquisition of Emperor Star, the transaction is accounted for as a restructuring transaction. All assets and liabilities of Emperor Star were transferred to the Company at their respective carrying amounts on the date of transaction. The Company has recast prior period financial statements to reflect the conveyance of Emperor Star’s common shares as if the restructuring transaction had occurred as of the earliest date of the consolidated financial statements. All material intercompany accounts, transactions, and profits have been eliminated in consolidation. The nature of and effects on earnings per share (EPS) of non-recurring intra-entity transactions involving long-term assets and liabilities is not required to be eliminated and EPS amounts have been recast to include the earnings (or losses) of the transferred net assets.
The functional currency of the subsidiaries in Taiwan is the New Taiwan dollars and the subsidiary in People’s Republic of China is the Chinese Yuan, or Renminbi; however, the accompanying consolidated financial statements have been translated and presented in United States Dollars ($). In the accompanying consolidated financial statements and notes, “$”, “US$” and “U.S. dollars” mean United States dollars, “NT$” and “NT dollars” mean New Taiwan dollars, and “RMB” means Chinese Yuan, or Renminbi.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.
Accounts Receivable
Accounts receivable are stated at carrying value less estimates made for doubtful receivables. An allowance for impairment of trade receivables is established if the collection of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate. An impairment loss is recognized in the statement of income, as are subsequent recoveries of previous impairments.
Inventory
Inventory is stated at the lower of cost and net realizable value. Net realizable value (NRV) is defined as estimated selling prices less costs of completion, disposal, and transportation. Inventory consists mainly of finished goods held for resale. Cost is determined on a weighted average cost method. The Company periodically reviews the age and turnover of its inventory to determine whether any inventory has become obsolete or has declined in value, and incurs a charge to operations for known and anticipated inventory obsolescence.
F-7 |
Property and Equipment
Property and equipment are carried at cost net of accumulated depreciation. Expenditures that improve the functionality of the related asset or extend the useful life are capitalized. When property and equipment is retired or otherwise disposed of, the related gain or loss is included in operating income. Leasehold improvements are depreciated on the straight-line method over the shorter of the remaining lease term or estimated useful life of the asset. Depreciation is calculated on the straight-line method, including property and equipment under capital leases, generally over five years. Depreciation expense was $408 and $636 for the six months ended June 30, 2023 and 2022, respectively.
Impairment of Long-Lived Assets
The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates its long-lived assets for impairment annually or more often if events and circumstances warrant. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve breakeven operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell. Impairment loss on property and equipment was $nil and $nil for the six months ended June 30, 2023 and 2022, respectively.
Revenue Recognition
Pursuant to ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines is within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration the Company is entitled to in exchange for the goods or services the Company transfers to the customers. At inception of the contract, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.
Merchandise sales: The Company recognizes sales revenues from merchandise sales when customers obtain control of the Company’s products, which typically occurs upon delivery to customer. Merchandise sales revenues are recorded at the sales price, or “transaction price”.
Software sales: The Company does not develop the software products on its own. When the Company receives a purchase order from the customer, the Company would engage with the third-party software company to customize and develop the software products. The Company recognizes software revenues upon completion of the installation and testing, and transfer the control of the software products to the customer. Software revenues are recorded at the fixed sales price, or “transaction price”, pursuant to the sales contracts. The Company may also charge the customer maintenance service fees on a straight-line basis over the service period pursuant to the sales contract. The Company concluded that the performance obligation for the maintenance service is distinct. Therefore, such maintenance service revenue can be separated from other elements in the arrangement.
Trade discount and allowances: The Company generally does not provide invoice discounts on product sales to its customers for prompt payment.
Product returns: The Company generally does not provide customers with the right to return a product for a full or partial refund, a credit, or an exchange for another product.
F-8 |
To date, product allowance and returns have been minimal and, based on its experience, the Company believes that returns of its products will continue to be minimal.
Since COVID-19 pandemic hit globally in 2020 and throughout first three quarters of financial year ended December 31, 2021, management assessed that the market conditions that it operated in was worsening. Credit risk on customers was determined to have deteriorated significantly as the majority of its customers were located in the PRC. Accordingly, management took the position that revenue would only be recognized when the consideration is received as to satisfy revenue recognition criteria related to reasonable certainty of collections.
During the fourth quarter of financial year ended December 31, 2021, the Covid pandemic was effectively controlled in the PRC. Management re-assessed the market conditions and determined that the overall market conditions were improving, and the Company’s collection history in the prior three quarters was positive, and in fourth quarter of 2021 reached sustainable recovery rate comparable to pre-COVID-19 environment. Accordingly, management decided that due to the improved conditions collection is now reasonably certain, and revenue is now recognized when risk and rewards are transferred to its customers.
The following tables provide details of revenue by major products and by geography.
Revenue by Major Products
For the six months ended June 30, 2023: |
||||
Nutrition supplement | $ | 247,084 | ||
Software | 5,950 | |||
Other | 471 | |||
Total | $ | 253,505 | ||
For the six months ended June 30, 2022: |
||||
Water purifier machine | $ | 12,105 | ||
Automobile carbon reduction machine | 8,993 | |||
Nutrition supplement | 55,486 | |||
Software | 53,161 | |||
Other | 2,440 | |||
Total | $ | 132,185 |
Revenue by Geography
For the six months ended June 30, 2023: |
|
|
|
|
Asia Pacific |
|
$ |
253,505 |
|
Total |
|
$ |
253,505 |
|
For the six months ended June 30, 2022: |
|
|
|
|
Asia Pacific |
|
$ |
132,185 |
|
Total |
|
$ |
132,185 |
|
Leases
The Company adopted FASB Accounting Standards Codification, Topic 842, Leases (“ASC 842”) using the modified retrospective approach, electing the practical expedient that allows the Company not to restate its comparative periods prior to the adoption of the standard on January 1, 2019. As such, the disclosures required under ASC 842 are not presented for periods before the date of adoption. For the comparative periods prior to adoption, the Company presented the disclosures which were required under ASC 842.
The new leasing standard requires recognition of leases on the consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities. ROU assets represent the Company’s right to use underlying assets for the lease terms and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. Operating lease ROU assets and operating lease liabilities are recognized based on the present value and future minimum lease payments over the lease term at commencement date. The Company’s future minimum based payments used to determine the Company’s lease liabilities mainly include minimum based rent payments. As most of Company’s leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.
F-9 |
In addition, the adoption of the standard did not have a material impact on the Company’s results of operations or cash flows. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in Selling, general and administrative expenses. Variable lease payments for common area maintenance, property taxes and other operating expenses are recognized as expense in the period when the changes in facts and circumstances on which the variable lease payments are based occur.
Advertising Costs
Advertising costs are expensed at the time such advertising commences. Advertising expenses were $114 and $2,040 for six months ended June 30, 2023 and 2022, respectively.
Stock-Based Compensation
The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation (“ASC 718”). Under the fair value recognition provisions, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as compensation expense on a straight-line basis over the requisite service period, based on the terms of the awards. The Company calculates the fair value of option grants utilizing the Black-Scholes pricing model and estimates the fair value of the stock based upon the estimated fair value of the common stock.
In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). ASU 2018-07 expands the guidance in ASC 718 to include share-based payments for goods and services to non-employees and generally aligns it with the guidance for share-based payments to employees. In accordance with ASU 2018-07, these stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The fair value of the equity instrument is charged directly to compensation expense and additional-paid-in capital over the period during which services are rendered.
Post-retirement and Post-employment Benefits
The Company’s subsidiaries in Taiwan adopted the government mandated defined contribution plan pursuant to the Taiwan Labor Pension Act (the “Act”). Such labor regulations require that the rate of contribution made by an employer to the Labor Pension Fund per month shall not be less than 6% of the worker’s monthly salaries. Pursuant to the Act, the Company makes monthly contribution equal to 6% of employees’ salaries to the employees’ pension fund. The Company has no legal obligation for the benefits beyond the contributions made. The total amounts for such employee benefits, which were expensed as incurred, were $2,339 and $2,844 for six months ended June 30, 2023 and 2022, respectively. Other than the above, the Company does not provide any other post-retirement or post-employment benefits.
F-10 |
Fair Value Measurements
FASB ASC 820, “Fair Value Measurements” defines fair value for certain financial and non-financial assets and liabilities that are recorded at fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. It requires that an entity measure its financial instruments to base fair value on exit price, maximize the use of observable units and minimize the use of unobservable inputs to determine the exit price. It establishes a hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy increases the consistency and comparability of fair value measurements and related disclosures by maximizing the use of observable inputs and minimizing the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the assets or liabilities based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy prioritizes the inputs into three broad levels based on the reliability of the inputs as follows:
Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Valuation of these instruments does not require a high degree of judgment as the valuations are based on quoted prices in active markets that are readily and regularly available.
Level 2 – Inputs other than quoted prices in active markets that are either directly or indirectly observable as of the measurement date, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 – Valuations based on inputs that are unobservable and not corroborated by market data. The fair value for such assets and liabilities is generally determined using pricing models, discounted cash flow methodologies, or similar techniques that incorporate the assumptions a market participant would use in pricing the asset or liability.
The carrying values of certain assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, inventory, advance to suppliers, prepaid expenses, accounts payable, accrued expenses, and due to shareholders, approximate fair value because of to their relatively short maturities.
Earnings (Loss) Per Share
Basic income (loss) per share is computed by dividing net income (loss) by weighted average number of shares of common stock outstanding during each period. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents, and potentially dilutive securities outstanding during each year. Dilutive shares are excluded the exercise price is greater than the average market price and when the Company incurred a net loss as the inclusion of such shares would have an anti-dilutive effect.
For the six months ended June 30, 2023 and 2022, warrants were excluded as dilutive shares as the Company incurred a net loss.
Income Taxes
The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when, in the opinion of management, it is more likely than not that some or all of any deferred tax assets will not be realized.
Foreign-currency Transactions
Foreign-currency transactions are recorded in New Taiwan dollars (“NTD”) and Renminbi (“RMB”) at the rates of exchange in effect when the transactions occur. Gains or losses resulting from the application of different foreign exchange rates when cash in foreign currency is converted into New Taiwan dollars and Renminbi, or when foreign-currency receivables or payables are settled, are credited or charged to income in the year of conversion or settlement. On the balance sheet dates, the balances of foreign-currency assets and liabilities are restated at the prevailing exchange rates and the resulting differences are charged to current income except for those foreign currencies denominated investments in shares of stock where such differences are accounted for as translation adjustments under stockholders’ equity.
Translation Adjustment
The accounts of the Company’s subsidiaries were maintained, and their financial statements were expressed in New Taiwan Dollar (“NTD”) and Chinese Yuan, or Renminbi (“RMB”). Such financial statements were translated into U.S. Dollars (“$” or “USD”) in accordance ASC 830, “Foreign Currency Matters”, with the NTD and RMB as the functional currency. According to the Statement, all assets and liabilities are translated at the current exchange rate, common stock and additional paid-in capital are translated at the historical rates, and income statement items are translated at an average exchange rate for the period. The resulting translation adjustments are reported under accumulated other comprehensive income (loss) as a component of stockholders’ equity.
F-11 |
Comprehensive Income (loss)
Comprehensive income (loss) includes accumulated foreign currency translation gains and losses. The Company has reported the components of comprehensive income (loss) on its consolidated statements of operations and other comprehensive income (loss).
Concentration of Credit Risk
Cash and cash equivalents
: The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments in high quality credit institutions in Taiwan, but these investments may be in excess of the insurance limits of Taiwan Central Deposit Insurance Corporation (the “TCDIC”) NT$ 3 million. The Company does not enter into financial instruments for hedging, trading or speculative purposes. Concentration of credit risk with respect to trade and notes receivables is limited due to the wide variety of customers and markets in which the Company transacts business, as well as their dispersion across many geographical areas. As of June 30, 2023, the Company had approximately $nil in excess of TCDIC insured limits. The Company has not experienced any losses in such accounts.
Customers
: The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral.
For the six months ended June 30, 2023, customer(s) accounted for more than 10% of the Company’s total revenues as follows.
Customer |
|
Net sales for the six months ended June 30, 2023 |
|
|
% of Total |
|
|
Accounts receivable balance as of June 30, 2023 |
|
|
% of Total |
|
||||
A |
|
$ |
5,950 |
|
|
|
2 |
% |
|
$ |
- |
|
|
|
- |
% |
B |
|
$ |
233,478 |
|
|
|
92 |
% |
|
$ |
35,384 |
|
|
|
27.3 |
% |
For the six months ended June 30, 2022, customer(s) accounted for more than 10% of the Company’s total revenues as follows.
Customer |
|
|
Net sales for the six months ended June 30, 2022 |
|
|
% of Total |
|
|
Accounts receivable balance as of June 30, 2022 |
|
|
% of Total |
|
|||||||||||||||||||||||||||||||
A |
|
|
$ |
|
|
|
|
59,254 |
|
|
|
45 |
% |
|
$ |
289,735 |
|
|
|
92 |
% |
|||||||||||||||||||||||
B
|
|
|
$
|
|
|
|
47,805
|
|
|
|
36
|
%
|
|
$
|
-
|
|
|
|
-
|
%
|
Suppliers
: The Company’s inventory is purchased from various suppliers.
F-12 |
For the six months ended June 30, 2023, supplier(s) accounted for more than 10% of the Company’s total net purchase as follows:
Supplier | Net purchase for the six months ended June 30, 2023 | % of Total | Accounts payable balance as of June 30, 2023 | % of Total | ||||||||||||
A | $ | 126,398 | 100 | % | $ | - | - | % |
For the six months ended June 30, 2022, supplier(s) accounted for more than 10% of the Company’s total net purchase as follows:
Supplier | Net purchase for the six months ended June 30, 2022 | % of Total | Accounts payable balance as of June 30, 2022 | % of Total | ||||||||||||
A | $ | 42,487 | 26 | % | $ | 50,853 | 100 | % | ||||||||
B | $ | 117,676 | 71 | % | $ | - | - | % |
Recent Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments.” This pronouncement, along with subsequent ASUs issued to clarify provisions of ASU 2016-13, changes the impairment model for most financial assets and will require the use of an “expected loss” model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. In developing the estimate for lifetime expected credit loss, entities must incorporate historical experience, current conditions, and reasonable and supportable forecasts. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019. On November 19, 2019, the FASB issued ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), finalized various effective date delays for private companies, not-for-profit organizations, and certain smaller reporting companies applying the credit losses (CECL), the revised effective date is January 2023.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
Note 2. LEASE
As of June 30, 2023, the Company has operating lease agreement for its car with remaining lease terms of 33 months, photocopier with remaining lease terms of 39 months, and office lease with remaining lease terms of 18 months, respectively. The Company does not have any other leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company accounts for the lease and non-lease components of its leases as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.
Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The discount rate used to calculate present value is incremental borrowing rate or, if available, the rate implicit in the lease. The Company determines the incremental borrowing rate for each lease based primarily on its lease term in Taiwan which is approximately 2.44%.
Operating lease expenses were $18,976 and $19,052 for the six months ended June 30, 2023 and 2022, respectively.
F-13 |
The components of lease expense and supplemental cash flow information related to leases for the six months ended are as follows:
Lease Cost |
June 30, 2023 |
June 30, 2022 |
||||||
Operating lease cost (included in general and administrative expenses in the Company’s statement of operations) |
$ |
18,976 |
19,052 |
|||||
Other Information |
||||||||
Right-of-use assets obtained in exchange for new operating leases liabilities |
- |
82,678 |
||||||
Cash paid for amounts included in the measurement of lease liabilities |
- |
- |
||||||
Weighted average remaining lease term – operating leases (in years) |
2.50 |
1.75 |
||||||
Average discount rate – operating lease |
2.44 |
% |
2.44 |
% |
The supplemental balance sheet information related to leases for the period is as follows:
June 30, 2023 |
December 31, 2022 |
|||||||
Operating leases | ||||||||
Right-of-use assets, net | $ | 96,579 | $ | 115,884 | ||||
Operating lease liabilities | $ | 96,579 | $ | 115,884 |
The future minimum lease payment schedule as follows:
For the periods ending June 30, |
||||
2023 (six months remaining) |
18,576 |
|||
2024 |
37,152 |
|||
2025 |
35,084 |
|||
2026 |
9,165 |
|||
Total lease payments |
99,977 |
|||
Less: Interest |
(3,398 |
) |
||
Total |
96,579 |
NOTE 3 – GOING CONCERN
The financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
As reflected in the financial statements, the Company had net losses for the six months ended June 30, 2023, and had negative working capital and accumulated deficit as of June 30, 2023. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
The Company’s cash position may not be sufficient to support the Company’s daily operations. Management has financed its operating costs with loans from director and officers. The Company intends to generate sufficient revenue and raise additional funds to support its operations, however there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further generate sufficient revenue and its ability to raise additional funds.
The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
F-14 |
Note 4. SECURITY DEPOSITS
On November 21, 2019, the Company and Shuang Hua International Culture Media Co, Ltd. (“Shuang Hua”), a corporation formed under laws of Taiwan, entered into an exclusive copyright and distribution agreement (the “Agreement”), pursuant to which, subject to the terms and condition therein, Shuang Hua granted the Company an exclusive right to produce, market, distribute and sell the bilingual films and electronic books of which the copyrights are owned by Shuang Hua. In accordance to the agreement, the Company shall pay Shuang Hua a refundable deposit of in the aggregate amount of $2,894,000, before December 31, 2021. The full deposit amounts have been provided for doubtful debt.
Note 5. RELATED PARTY TRANSACTIONS
Related parties of the Company during the six months ended June 30, 2023 and 2022 consist of the following:
Name of Related Party |
|
Nature of Relationship |
Yu Cheng Yang |
|
Majority Shareholder, Director and Officer of the Company |
Co-Innovation Group Limited |
|
Company under control of Yu Cheng Yang |
World Capital Holding Limited |
|
Company under control by Shanghai Qifan Qiye Management Co., Ltd.’s shareholders, former non-controlling interest of the Company |
Due to shareholders
The Company has advanced funds from its directors and shareholders Yu Cheng Yang for working capital purposes. As of June 30, 2023 and December 31, 2022, there were $505,709 and $277,080 advance outstanding, respectively. The Company has agreed that the outstanding balances bear 0% interest rate and are due upon demand after thirty days of written notice by the director and shareholder.
Mr. Yang advanced $290,075 to the Company as working capital, and the Company repaid $51,831 to Mr. Yang for the six months ended June 30, 2023.
Mr. Yang advanced $304,088 to the Company as working capital, and the Company repaid $114,378 to Mr. Yang for the six months ended June 30, 2022.
Note 6. TERM LOAN
Loan from First Commercial Bank
On September 30, 2020, TWD 3,000,000 (approximately $107,750
)
term loan was granted to the Company for working capital with repayment period of 60 months. The term loan is subject to an interest charge at 1% per annum for the first 9 months of the term loan; interest charges on the term loan from 10th
to 60th
is 3.5% per annum.On September 30, 2020, TWD 2,000,000 (approximately $71,833
)
term loan was granted to the Company for employee salary with repayment period of 30 months. The term loan is subject to an interest charge at 1.5% per annum for the first 9 months of the term loan; interest charges on the term loan from 10th
to 60th
is 1.845% per annum.Loan from Bank of Taiwan
On May 7, 2021, TWD 4,000,000 (approximately $143,666
)
term loan was granted to the Company for employee salary with repayment period of 60 months. The term loan is subject to an interest charge at 1% per annum for the first 8 months of the term loan; interest charges on the term loan from 9th
to 60th
is 1.9% per annum.On May 7, 2021, TWD 1,000,000 (approximately $35,917
)
term loan was granted to the Company for employee salary with repayment period of 60 months. The term loan is subject to an interest charge at 1.5% per annum for the first 8 months of the term loan; interest charges on the term loan from 9th
to 60th
is 2% per annum.As of June 30, 2023, the outstanding balance of the term loan is $145,585, of which $58,941 is due within one year and classified as short term, and $86,644 is due after one year, and has classified as long term, respectively.
F-15 |
As of December 31, 2022, the outstanding balance of the term loan is $184,509, of which $68,497 is due within one year and classified as short term, and $116,012 is due after one year, and has classified as long term.
Interest expenses were $2,666 and $1,681 for the six months ended June 30, 2023 and 2022, respectively.
Note 7. STOCKHOLDERS’ EQUITY
Preferred Stock
On July 8, 2021, the board of directors of the Company amended its stock designation and the Company is authorized to issue 5,000,000 shares of Series A Preferred Stock with par value $0.001. Each stock is entitled to 1,000 votes of common stock without dividend rights.
As of June 30, 2023, the Company has 1,500,000 shares of Series A Preferred Stock issued and outstanding.
Common Stock
On May 19, 2022, the Company issued 3,601,306
shares of restricted post-split common stock to non-employees, namely Exchange Listing, LLC, the amount is recorded as deferred (unearned) compensation of
$38,534, due to the corporate advisory
service has not been started.On May 19, 2022, the Company issued 115,000 shares of restricted
post-split
common stock to non-employees as compensation in the amount of $1,231.On August 18, 2021, the Company completed and closed a series of transactions to reorganize the Company’s structure and to develop its business by acquiring certain minority control interest of its subsidiary and intellectual properties. Pursuant to the Intellectual Property Transfer Agreement, the Company issue 15,000,000
d
75,000,000 shares of post-split Common Stock to Co-Innovation Group Limited, for the intellectual properties concerned. Pursuant to the Shareholders’ Agreement of Shanghai Maosong Trading Co., Ltd and Equity Pledge Agreements, the Companyissued
shares of post-split Common Stock to World Capital Holding Ltd, a substantial shareholder of the Company represented by YanPing SHENG, for the minority controlling interests of the intellectual properties holding subsidiary.
On July 8, 2021, the Company issued 75,000,000 shares of post-split Common Stock at $0.001 per share t
o convert outstanding debt owed to Co-Innovation Group Limited in the amount of $75,000.
On July 8, 2021, the Company issued 15,000,000 shares of post-split Common Stock at $0.001 per share to convert outstanding debt owed to World Capital Holding Ltd in the amount of $15,000.
On March 31, 2021, the Company’s board of directors and stockholders authorized a reverse stock split of its outstanding common stock at a ratio of 1-for-1000 without any change in the par value per share which became effective on April 7, 2021 upon approval by FINRA. The number of shares and price per share in the financial statements have been retrospectively adjusted accordingly to reflect this reverse stock split.
On March 16, 2021, the authorized shares of common stock were increased from 75,000,000 to 575,000,000 shares and the par value remains at $0.001.
As of June 30, 2023, the Company has 183,781,560 shares of Common Stock issued and outstanding.
Warrants
On February 3, 2022, the Company granted the issuance of warrants to purchase 200,000 shares of the Company’s common stock at an exercise price of $2 per share with an expiration date of December 22, 2027 to a consultant or its designees as compensation. The warrants were fully vested upon issuance.
A summary of warrant activities as follows:
|
|
Number of Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contractual Term (Years) |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Warrants outstanding at December 31, 2022 |
|
|
200,000 |
|
|
$ |
2.00 |
|
|
|
4.98 |
|
Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Expired |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Warrants outstanding at June 30, 2023 |
|
|
200,000 |
|
|
$ |
2.00 |
|
|
|
4.48 |
|
Warrants exercisable at June 30, 2023 |
|
|
200,000 |
|
|
$ |
2.00 |
|
|
|
4.48 |
|
F-16 |
Note 8. STOCK BASED COMPENSATION
Restricted Stock
On May 19, 2022, the Company issued 3,601,306 shares of restricted common stock to non-employees, the amount is recorded as deferred (unearned) compensation of $38,534, due to the service has not been started. The fair value of the shares was determined based on a contemporaneous valuation report.
On May 19, 2022, the Company issued 115,000 shares of restricted common stock to non-employees as compensation in the amount of $1,231. The shares were fully vested upon issuance as there were no other conditions required for the shares to vest. The fair value of the shares was determined based on a contemporaneous valuation report.
Warrants
On February 3, 2022, the Company granted the issuance of warrants to purchase 200,000 shares of the Company’s common stock at an exercise price of $2 per share with an expiration date of December 22, 2027 to a consultant or its designees as compensation. The warrants were fully vested upon issuance as there were no other conditions required for the warrants to vest.
In accordance to ASC 815-40, an equity-linked financial instrument can be classified in equity only if it (1) is indexed to the reporting entity’s own stock and (2) meets all other conditions for equity classification. The warrants are classified as equity instruments because a fixed amount of cash is exchanged for a fixed amount of equity.
The fair value of the warrants was determined using the Black-Scholes option pricing model which requires the input of subjective assumptions, the expected life of the warrants, and the expected stock price volatility. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.
The assumptions used to determine the initial fair value of the Warrants at inception as follows:
|
|
Years Ended December 31, |
|
|||||
|
|
2022 |
|
|
2021 |
|
||
Expected life (years) |
|
|
5.89 |
|
|
|
N/A |
|
Risk-free interest rate |
|
|
0.76 |
% |
|
|
N/A |
|
Expected volatility |
|
|
329.86 |
% |
|
|
N/A |
|
Dividend yield |
|
|
0 |
% |
|
|
N/A |
|
The expected life of the warrants was estimated using the “simplified method,” as the Company has no historical information to develop reasonable expectations about future exercise patterns for its warrant grants. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued.
For stock price volatility, the Company calculated its expected volatility based on historical closing price of its common stock, par value $0.001 per share. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the warrant at the grant-date.
Stock based compensation were $
nil
and $1,231 for the six months ended June 30, 2023 and 2022, respectively.Note 9. INCOME TAXES
United States
EOS, Inc. is incorporated in the United States of America and is subject to United States federal taxation at tax rate of 21%. No provisions for income taxes have been made as the Company has no taxable income for the period. As of June 30, 2023, the Company had net operating loss carry forwards of $1,439,794 that may be available to reduce future years’ taxable income. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements as their realization is determined not likely to occur and, accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards. No tax benefit has been realized since a 100% valuation allowance has offset deferred tax asset resulting from the net operating losses.
F-17 |
British Virgin Islands
EOS International Inc. is incorporated in British Virgin Islands and are not required to pay income tax.
Taiwan
The subsidiary of EOS Inc. and Emperor Star is incorporated in Taiwan. According to the amendments to the “Taiwan Income Tax Act” enacted by the office of the President of Taiwan on February 7, 2018, statutory income tax rate increased from 17% to 20% and undistributed earning tax decreased from 10% to 5%, effective from January 1, 2018.
People’s Republic of China (“PRC”)
Under the Enterprise Income Tax (“EIT”) Law of the PRC, the standard EIT rate is 25%. The PRC subsidiary of the Company is subject to PRC income taxes on an entity basis on income arising in or derived from the tax jurisdiction in which they operate. No provision for income taxes have been made as Maosong had no taxable income as of and for the six months ended June 30, 2023.
Provision for income tax consists of the following:
Six months ended June 30, | ||||||||
2023 | 2022 | |||||||
Current income tax (benefit) | ||||||||
U.S. | $ | - | $ | - | ||||
Taiwan | - | - | ||||||
PRC | - | - | ||||||
Sub total | - | - | ||||||
Deferred income tax | ||||||||
Deferred tax assets for NOL carry-forwards | (53,144 | ) | (72,025 | ) | ||||
Valuation allowance | 53,144 | 72,025 | ||||||
Other adjustments | - | - | ||||||
Net changes in deferred income tax (benefit) | - | - | ||||||
Total income tax provision | $ | - | $ | - |
The net loss before income taxes and its provision for income taxes as follows:
Six months ended June 30, | ||||||||
2023 | 2022 | |||||||
Net loss before income tax | (295,245 | ) | (352,941 | ) | ||||
Effective statutory tax rate | 18 | % | 20 | % | ||||
Income tax provision | (53,144 | ) | (70,588 | ) | ||||
Computed expected benefit | - | 10,475 | ||||||
Valuation allowance | 53,144 | 72,025 | ||||||
Non-taxable income | - | - | ||||||
Other adjustments, primarily the difference in tax rates | - | (1,437 | ) | |||||
Income tax expenses, net | - | 10,475 |
Significant components of the Company’s deferred taxes assets as follows:
Deferred tax assets: | June 30, 2023 | December 31, 2022 | ||||||
Net operating loss carry-forwards | 326,139 | 284,605 | ||||||
Less: Valuation allowance | (326,139 | ) | (284,605 | ) | ||||
Deferred tax assets, net | - | - |
F-18 |
Note 10. COMMITMENTS AND CONTINGENCIES
Sales Collaboration Agreement
On June 1, 2020, the Company and Fortune King entered into a sales collaboration agreement (the “Sales Collaboration Agreement”), pursuant to which, subject to the terms and condition therein, Fortune King agreed to provide promotional and marketing service of the Company’s products within six years from January 2020 to December 2025. Fortune King is obligated to perform such service regardless of whether the Company sells products to Fortune King during the designated period. In accordance with the Sales Collaboration Agreement and in consideration for the service provided by Fortune King, the Company shall issue 3,000,000 shares of common stock to Fortune King for the promotional and marketing service of $1,500,000. The 3,000,000 shares were issued on December 29, 2020.
The Company recognized the stock-based compensation of marketing expenses based on quarterly basis, with a quarterly marketing expense of $62,500. There are 24 quarters in total.
Copyright and Distribution Agreement
On November 21, 2019, the Company and Shuang Hua International Culture Media Co, Ltd. (“Shuang Hua”), a corporation formed under laws of Taiwan, entered into an exclusive copyright and distribution agreement (the “Agreement”), pursuant to which, subject to the terms and condition therein, Shuang Hua granted the Company an exclusive right to produce, market, distribute and sell the bilingual films and electronic books of which the copyrights owned by Shuang Hua. In accordance to the agreement, the Company shall pay Shuang Hua a refundable deposit of in the aggregate amount of $2,894,000, before December 31, 2021.
As of December 31, 2022, the Company has paid $1,013,541 to Shuang Hua, respectively, and are recorded as other long-term assets. Due to Covid-19 in 2020, the Company has not started its business plan with the exclusive copyright and distribution agreement, and such amount paid has been fully impaired as of December 31, 2022.
Note 11. SUBSEQUENT EVENTS
Management has evaluated subsequent events through the date which the financial statements are available to be issued. All subsequent events requiring recognition as of June 30, 2023 have been incorporated into these consolidated financial statements and there are no other subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”
F-19 |
The following discussion and analysis of the results of operations and financial condition of EOS Inc. and its subsidiary(“EOS” or the “Company”) as of June 30, 2023 for the three and six months ended June 30, 2023 and 2022 should be read in conjunction with our unaudited financial statements and the notes to those unaudited financial statements that are included elsewhere in this Quarterly Report on Form 10-Q. References in this Management’s Discussion and Analysis of Financial Condition and Results of Operations to “us”, “we”, “our” and similar terms refer to EOS. This Quarterly Report contains forward-looking statements as that term is defined in the federal securities laws. The events described in forward-looking statements contained in this Quarterly Report may not occur. Generally, these statements relate to business plans or strategies, projected or anticipated benefits or other consequences of our plans or strategies, projected or anticipated benefits from acquisitions to be made by us, or projections involving anticipated revenues, earnings or other aspects of our operating results. The words “may,” “will,” “expect,” “believe,” “anticipate,” “project,” “plan,” “intend,” “estimate,” and “continue,” and their opposites and similar expressions, are intended to identify forward-looking statements. We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond our control, which may influence the accuracy of the statements and the projections upon which the statements are based.
Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. Except as required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.
U.S. Dollars are denoted herein by “USD,” “$” and “dollars”.
Overview
EOS Inc. was incorporated in the State of Nevada on April 3, 2015.
On or about November 18, 2016, the Company formed EOS INC. TAIWAN BRANCH, a Taiwanese corporation (“EITB”) and the Company owns 100% of EITB. Yu-Cheng Yang, a shareholder and director of the Company, is the sole director of EITB. Yu-Hsiang Chia is the branch manager of EITB.
Emperor Star International Trade Co., Ltd., (“Emperor Star”), was incorporated on November 16, 2015 under the laws of Taiwan. Emperor Star is in the business of marketing and distributing various consumer products, including detergents, nutrition supplements, and skin care products.
Results of Operation
The following presents the consolidated result of the Company for the three months ended June 30, 2023 compared to the three months ended June 30, 2022.
Net sales
Net sales were $82,426 for three months ended June 30, 2023, representing a decrease of $16,695 or 16.8%, as compared to $99,121 for the three months ended June 30, 2022. The decrease was primarily due to changes to the category of products sold.
Cost of sales
Cost of sales was $28,530 for the three months ended June 30, 2023, representing a decrease of $13,694 or 32.4%, as compared to $42,224 for the three months ended June 30, 2022.
3 |
Gross profit
Gross profit was $53,896 for the three months ended June 30, 2023, compared to $56,897 for the same period in 2022. Gross profit as a percentage of net sales was 65.4% for the three months ended June 30, 2023, compared to 57.4% in the same period in 2022. The increase was primarily due to categories of products sold during each of the periods ended.
Selling, general and administrative expenses
Selling, general and administrative expenses consist primarily of office rent, salary and related costs for personnel and facilities, and professional service fees. Selling, general and administrative expenses were $218,537 for the three months ended June 30, 2023, representing an increase of $7,966 or 3.8%, as compared to $210,571 for the three months ended June 30, 2022.
Income (loss) from operations
Loss from operations was $164,641 for the three months ended June 30, 2023 compared to loss from operations of $153,674 for the three months ended June 30, 2022, representing an increase of $10,967 or 7.1%. Such increase was primarily due to the decrease in sales and cost of sales with an increase in selling, general and administrative expenses.
Other income (loss)
Other loss was $467 for the three months ended June 30, 2023, reflecting a decrease of $7,048, or 107.1%, compared to other income of $6,581 for the three months June 30, 2022. The decrease was mainly attributable to investment disposal loss in the prior period.
Net loss
As a result of the above factors, our net loss was $165,108 for the three months ended June 30, 2023, as compared to net loss of $136,618 for the three months ended June 30, 2022, representing an increase in loss of $28,490 or 20.9%.
The following presents the consolidated result of the Company for the six months ended June 30, 2023 compared to the six months ended June 30, 2022
Net sales
Net sales were $253,505 for six months ended June 30, 2023, representing an increase of $121,320, or 91.8%, as compared to $132,185 for the six months ended June 30, 2022. The increase was primarily due to the sales decreased impacted by the epidemic in the previous year.
Cost of sales
Cost of sales was $86,703 for the six months ended June 30, 2022, representing an increase of $37,804 or 77.3%, as compared to $48,899 for the six months ended June 30, 2022.
Gross profit
Gross profit was $166,802 for the six months ended June 30, 2023, compared to $83,286 for the same period in 2022. Gross profit as a percentage of net sales was 65.8% for the six months ended June 30, 2023, compared to 63.0% in the same period in 2022. The increase in gross profit margin is due to different categories of products sold for each period.
Selling, general and administrative expenses
Selling, general and administrative expenses consist primarily of office rent, salary and related costs for personnel and facilities, and professional service fees. Selling, general and administrative expenses were $460,863 for the six months ended June 30, 2023, representing an increase of $20,209 or 4.6%, as compared to $440,654 for the six months ended June 30, 2022.
Income (loss) from operations
Loss from operations was $294,061 for the six months ended June 30, 2023 compared to loss from operations of $357,368 for the six months ended June 30, 2022, representing a decrease of $63,307 or 17.7%. Such decrease was primarily due to the increase in sales with higher profit margin.
Other income (loss)
Other loss was $1,184 for the six months ended June 30, 2023, reflecting a decrease of $4,380, or 137.0%, compared to other income of $3,196 for the three months June 30, 2022.
Net loss
As a result of the above factors, our net loss was $295,245 for the six months ended June 30, 2023, as compared to net loss of $343,697 for the six months ended June 30, 2022, representing a decrease in loss of $48,452 or 14.1%.
Liquidity and Capital Resources
Cash and cash equivalents were $26,600 at June 30, 2023 and $18,169 at December 31, 2022. Our total current assets were $416,025 at June 30, 2023, as compared to $425,916 at December 31, 2022. Our total current liabilities were $1,573,793 at June 30, 2023, as compared to $1,266,234 at December 31, 2022.
We had a working capital deficit of $1,157,768 on June 30, 2023, compared to the working capital deficit of $840,318 on December 31, 2022. The increase in working capital deficit was primarily attributable to the increase in amount due to shareholders and increased in inventory.
Net cash used in operating activities was $191,718 during the six months ended June 30, 2023, as compared to $63,667 for the six months ended June 30, 2022. The net cash used in operating activities increased $128,051 was primary attributable to the decrease in net losses with an increase in accounts payables and other payables.
Net cash used in investing activities was $1,091 during the six months ended June 30, 2023, as compared to $19,919 for the six months ended June 30, 2022. The decrease in net cash used in investing activities was due to the decrease in the acquisition of equipment.
Net cash provided by financing activities was $201,698 during the six months ended June 30, 2023, as compared to $150,718 for the six months ended June 30, 2022. The increase in net cash provided by financing activities was due to the proceeds from related party payable.
As a result of the above factors, net increase in cash and cash equivalents were $8,431 for the six months ended June 30, 2023, as compared to net increase of $63,187 for the six months ended June 30, 2022.
4 |
Critical Accounting Policies
Please refer to Note 1 in the notes to our consolidated financial statements included in this report for the Company’s complete critical accounting policies.
Principles of Consolidation
The accompanying consolidated financial statements, including the accounts of EOS Inc. and its wholly owned subsidiaries in Taiwan, British Virgin Islands, and People’s Republic of China, have been prepared in conformity with accounting principles generally accepted in the United States of America. Since the Company and Emperor Star are entities under common control prior to the acquisition of Emperor Star, the transaction is accounted for as a restructuring transaction. All assets and liabilities of Emperor Star were transferred to the Company at their respective carrying amounts on the date of transaction. The Company has recast prior period financial statements to reflect the conveyance of Emperor Star’s common shares as if the restructuring transaction had occurred as of the earliest date of the consolidated financial statements. All material intercompany accounts, transactions, and profits have been eliminated in consolidation. The nature of and effects on earnings per share (EPS) of non-recurring intra-entity transactions involving long-term assets and liabilities is not required to be eliminated and EPS amounts have been recast to include the earnings (or losses) of the transferred net assets.
The functional currency of the subsidiaries in Taiwan is the New Taiwan dollars and the subsidiary in People’s Republic of China is the Chinese Yuan, or Renminbi; however, the accompanying consolidated financial statements have been translated and presented in United States Dollars ($). In the accompanying consolidated financial statements and notes, “$”, “US$” and “U.S. dollars” mean United States dollars, “NT$” and “NT dollars” mean New Taiwan dollars, and “RMB” means Chinese Yuan, or Renminbi.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.
Accounts Receivable
Accounts receivable are stated at carrying value less estimates made for doubtful receivables. An allowance for impairment of trade receivables is established if the collection of a receivable becomes doubtful. Such receivable becomes doubtful when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired. The amount of the allowance is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the original effective interest rate. An impairment loss is recognized in the statement of income, as are subsequent recoveries of previous impairments.
Inventory
Inventory is stated at the lower of cost and net realizable value. Net realizable value (NRV) is defined as estimated selling prices less costs of completion, disposal, and transportation. Inventory consists mainly of finished goods held for resale. Cost is determined on a weighted average cost method. The Company periodically reviews the age and turnover of its inventory to determine whether any inventory has become obsolete or has declined in value, and incurs a charge to operations for known and anticipated inventory obsolescence.
5 |
As a smaller reporting company, we are not required to provide this information.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to provide reasonable assurance that material information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that the information is accumulated and communicated to our management, including our Chief Executive Officer and interim Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. We performed an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. During our assessment of the effectiveness of internal control over financial reporting as of June 30, 2023, management identified material weaknesses related to (i) our internal audit functions (ii) inadequate levels of review of the financial statements, (iii) a lack of segregation of duties within accounting functions and (iv) the absence of any independent directors. Therefore, our internal controls over financial reporting were not effective as of June 30, 2023.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures is also based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Material Weaknesses and Corrective Actions
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal controls over financial reporting that occurred during our last fiscal quarter to which this Quarterly Report on Form 10-Q relates that have materially affected, or are reasonably likely to materially affect our internal controls over financial reporting.
We are not currently involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, or proceeding by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or our subsidiary, threatened against or affecting our Company, our common stock, our subsidiary or of our companies or our subsidiary’s officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.
6 |
As a smaller reporting company, we are not required to provide this information.
None.
None.
Not applicable.
On April 27, 2023, the Company started a restructuring in preparation to up-list to OTCQB very soon. The Company has fulfilled the QB up list requirement of a minimum 10% public float with 50 UBOs as per current.
On August 1, 2023, Mr. Zongjiang He was appointed by the Company as the acting CFO and Treasurer due to his vast experiences in public-listed internal control management. He’s appointment is to provide a wholesome internal control review on the Company’s Internal Control financial reporting as a preparation to phase into the Nasdaq Capital Market in Q2 2024, in addition to strengthening any possible weaknesses of the Group.
The Board is in discussion of a possible reverse split, limited to a maximum of 5-for-1, whereby the Management believes the decision is in the best interests of the Company. The Management anticipates the reverse split as part of the restructuring to bring the price per share to be above Penny Stock Price for more than 90 days. And by such achievement, the Company shall be able to fulfill BlueSky terms, allowing the Company shares to be accepted and traded by global brokerage firms.
Since the appointment, He has been actively doing research on possible Take-Overs of profitable operations with positive assets, with careful consideration not to exert the dilution of existing shareholders. He targets to have the Company back in the black with a range of USD 5 million to 10 million of positive assets.
The Company is currently in the midst of a discussion with a Hong Kong main board-listed professional investment company, and we are actively seeking placing of our shares to this professionally licensed institutional investor. This Hong Kong main board-listed company has extensive knowledge in selecting high-tech listed vehicles. We believe that we have a very high possibility to collaborate with this institutional investor in the near future with the assistance of Mr He.
The Company is also in the midst of revamping the existing domain and will announce the new site once it is ready, together with other upcoming public announcements to reach the investment public aware of the Company’s latest development.
The following exhibits are filed herewith:
Exhibit No. | Description | |
31.1 | Certification of Chief Executive and Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. | |
32.1 | Certification of Chief Executive and Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, is formatted in Inline XBRL. |
7 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
EOS Inc. | ||
Date: August 14, 2023 | By: | /s/ He-Siang Yang |
He-Siang Yang | ||
CEO, President, Secretary and Chairman of the Board |
8 |